Detalles de la búsqueda
1.
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy.
Med Sci Monit;
29: e940124, 2023 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37454245
2.
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China.
Chin J Cancer Res;
34(6): 592-600, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36714346
3.
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.
Oncologist;
25(10): e1473-e1480, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333626
4.
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol;
20(6): 806-815, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036468
5.
Association of PTPN1 polymorphisms with breast cancer risk: A case-control study in Chinese females.
J Cell Biochem;
120(7): 12039-12050, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30805963
6.
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Breast Cancer Res Treat;
168(2): 389-399, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29230663
7.
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial.
Lancet Oncol;
18(3): 371-383, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209298
8.
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Oncologist;
22(12): 1431-1443, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28912152
9.
The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?
Tumour Biol;
37(7): 9555-63, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26790445
10.
Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Mol Cancer;
14: 102, 2015 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25972084
11.
[Expression of HIF-1α and correlation with angiogenesis in tissue of breast cancer complicated with diabetes].
Zhonghua Yi Xue Za Zhi;
95(4): 252-5, 2015 Jan 27.
Artículo
en Zh
| MEDLINE | ID: mdl-25877238
12.
[Efficacies of aromatase inhibitors in the treatment of hormone dependent metastatic breast cancer in postmenopausal women: a report of 148 cases].
Zhonghua Yi Xue Za Zhi;
95(22): 1765-7, 2015 Jun 09.
Artículo
en Zh
| MEDLINE | ID: mdl-26704164
13.
Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer.
Pak J Pharm Sci;
28(3 Suppl): 1055-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26051718
14.
Screening of the miRNAs related to breast cancer and identification of its target genes.
Eur J Gynaecol Oncol;
35(6): 696-700, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25566594
15.
[Analysis of predictive factors affecting sentinel lymph node status in early breast cancer patients].
Zhonghua Zhong Liu Za Zhi;
36(3): 198-201, 2014 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-24785280
16.
[Influencing factors of pathologic complete response after neoadjuvant chemotherapy in locally advanced breast cancer patients: results of a single-center 10-year retrospective study].
Zhonghua Yi Xue Za Zhi;
94(18): 1401-4, 2014 May 13.
Artículo
en Zh
| MEDLINE | ID: mdl-25142991
17.
Maintenance treatment of trastuzumab for patients with advanced breast cancer to achieve long term survival: two case reports and literature review.
Chin J Cancer Res;
26(4): 486-92, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25232224
18.
Efficacy of capecitabine-based combination therapy and single-agent capecitabine maintenance therapy in patients with metastatic breast cancer.
Chin J Cancer Res;
26(6): 692-7, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25561767
19.
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
Nat Commun;
15(1): 2153, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38461323
20.
[Effects of high glucose on in vitro invasiveness of human breast cancer cell line MDA-MB-435].
Zhonghua Yi Xue Za Zhi;
93(2): 89-92, 2013 Jan 08.
Artículo
en Zh
| MEDLINE | ID: mdl-23648341